Yumanity Therapeutics Inc

NASDAQ:YMTX   3:59:51 PM EDT
10.58
+0.09 (+0.86%)
Other Pre-Announcement

Yumanity Therapeutics Posts Q2 Loss Per Share Of $1.03

Published: 08/12/2021 21:12 GMT
Yumanity Therapeutics Inc (YMTX) - Yumanity Therapeutics Reports Second Quarter 2021 Financial Results and Recent Corporate Developments.
Q2 Loss per Share $1.03.
Q2 Earnings per Share Estimate $-0.84 -- Refinitiv Ibes Data (analyst estimates).
Topline Results for Ytx-7739 Phase 1b Trial in Parkinson's Disease Patients Expected Fall of 2021.
As of June 30, 2021, Cash, Cash Equivalents and Investments Was $55.6 Million.